A detailed history of Alliancebernstein L.P. transactions in Zoetis Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 14,974,320 shares of ZTS stock, worth $2.74 Billion. This represents 0.93% of its overall portfolio holdings.

Number of Shares
14,974,320
Previous 12,410,543 20.66%
Holding current value
$2.74 Billion
Previous $2.1 Billion 23.62%
% of portfolio
0.93%
Previous 0.76%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$145.54 - $178.83 $373 Million - $458 Million
2,563,777 Added 20.66%
14,974,320 $2.6 Billion
Q1 2024

May 14, 2024

SELL
$165.67 - $199.94 $27 Million - $32.6 Million
-162,907 Reduced 1.3%
12,410,543 $2.1 Billion
Q4 2023

Feb 14, 2024

SELL
$151.44 - $200.09 $292 Million - $386 Million
-1,927,388 Reduced 13.29%
12,573,450 $2.48 Billion
Q3 2023

Nov 14, 2023

SELL
$167.14 - $192.77 $270 Million - $311 Million
-1,614,729 Reduced 10.02%
14,500,838 $2.52 Billion
Q2 2023

Aug 15, 2023

SELL
$160.94 - $186.23 $400 Million - $462 Million
-2,482,515 Reduced 13.35%
16,115,567 $2.78 Billion
Q1 2023

May 15, 2023

SELL
$145.48 - $175.02 $133 Million - $160 Million
-912,130 Reduced 4.68%
18,598,082 $3.1 Billion
Q4 2022

Feb 14, 2023

BUY
$131.14 - $157.47 $53.5 Million - $64.3 Million
408,101 Added 2.14%
19,510,212 $2.86 Billion
Q3 2022

Nov 15, 2022

BUY
$148.29 - $182.55 $60.6 Million - $74.5 Million
408,379 Added 2.18%
19,102,111 $2.83 Billion
Q2 2022

Aug 15, 2022

BUY
$155.97 - $200.09 $47.9 Million - $61.4 Million
307,074 Added 1.67%
18,693,732 $3.21 Billion
Q1 2022

May 13, 2022

BUY
$181.39 - $234.03 $131 Million - $169 Million
723,333 Added 4.1%
18,386,658 $3.47 Billion
Q4 2021

Feb 14, 2022

BUY
$193.69 - $247.03 $85.5 Million - $109 Million
441,440 Added 2.56%
17,663,325 $4.31 Billion
Q3 2021

Nov 10, 2021

BUY
$189.29 - $209.69 $96.2 Million - $107 Million
508,358 Added 3.04%
17,221,885 $3.34 Billion
Q2 2021

Jul 30, 2021

SELL
$155.9 - $187.99 $173 Million - $209 Million
-1,110,206 Reduced 6.23%
16,713,527 $3.11 Billion
Q1 2021

May 06, 2021

BUY
$144.0 - $169.39 $170 Million - $200 Million
1,178,470 Added 7.08%
17,823,733 $2.81 Billion
Q4 2020

Feb 08, 2021

BUY
$157.07 - $174.35 $218 Million - $242 Million
1,386,823 Added 9.09%
16,645,263 $2.75 Billion
Q3 2020

Nov 12, 2020

BUY
$137.1 - $165.37 $63.2 Million - $76.2 Million
460,842 Added 3.11%
15,258,440 $2.52 Billion
Q2 2020

Aug 13, 2020

BUY
$111.92 - $142.53 $68.8 Million - $87.7 Million
615,128 Added 4.34%
14,797,598 $2.03 Billion
Q1 2020

May 14, 2020

BUY
$92.66 - $144.94 $21.1 Million - $33.1 Million
228,082 Added 1.63%
14,182,470 $1.67 Billion
Q4 2019

Feb 18, 2020

SELL
$116.25 - $133.25 $19.6 Million - $22.5 Million
-168,956 Reduced 1.2%
13,954,388 $1.85 Billion
Q3 2019

Nov 14, 2019

SELL
$112.57 - $128.43 $101 Million - $116 Million
-901,457 Reduced 6.0%
14,123,344 $1.76 Billion
Q2 2019

Aug 14, 2019

BUY
$97.98 - $114.28 $3.62 Million - $4.22 Million
36,912 Added 0.25%
15,024,801 $1.71 Billion
Q1 2019

May 14, 2019

BUY
$81.56 - $100.67 $118 Million - $145 Million
1,441,288 Added 10.64%
14,987,889 $1.51 Billion
Q4 2018

Feb 13, 2019

BUY
$79.28 - $95.27 $58 Million - $69.6 Million
731,054 Added 5.7%
13,546,601 $1.16 Billion
Q3 2018

Nov 08, 2018

SELL
$83.5 - $93.23 $47 Million - $52.5 Million
-562,997 Reduced 4.21%
12,815,547 $1.17 Billion
Q2 2018

Aug 13, 2018

BUY
$79.9 - $89.2 $12.7 Million - $14.2 Million
159,433 Added 1.21%
13,378,544 $1.14 Billion
Q1 2018

May 14, 2018

SELL
$71.51 - $84.69 $78.1 Million - $92.5 Million
-1,091,947 Reduced 7.63%
13,219,111 $1.1 Billion
Q4 2017

Feb 13, 2018

SELL
$63.24 - $72.8 $28.2 Million - $32.5 Million
-446,599 Reduced 3.03%
14,311,058 $1.03 Billion
Q3 2017

Nov 13, 2017

BUY
$59.73 - $65.4 $881 Million - $965 Million
14,757,657
14,757,657 $941 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $85.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.